---
title: "台湾集体诉讼控告小林制药关于红曲米补充剂"
description: "台湾集体诉讼控告小林制药关于红曲米补充剂"
image: https://image.informedainews.com/2024/09/Hea-RxV-1727519337-0.jpg
---


:::info

“智闻AI“ 是由人工智能编撰的刊物集合，确保您只获得最有价值的信息，旨在助您消除信息差，突破信息茧房的局限。  [了解更多 >>](/)

:::

# 台湾集体诉讼控告小林制药关于红曲米补充剂

import Tabs from '@theme/Tabs';
import TabItem from '@theme/TabItem';

<Tabs
	defaultValue="summary"
	values={[
	{label: 'summary', value: 'summary'},
	{label: 'score', value: 'score'},
]}>
<TabItem value="summary">
<img
  src="https://image.informedainews.com/2024/09/Hea-RxV-1727519337-0.jpg"
  alt="Taiwan Class Action Lawsuit Against Kobayashi Pharma Over Red Yeast Rice Supplements"
/>



台湾地区已对小林制药提起集体诉讼，指控该公司的红曲米膳食补充剂对55人造成伤害。这些补充剂在日本已与超过100例死亡事件有关。该诉讼寻求532万美元的赔偿。根据日本卫生部的说法，补充剂中含有的曲霉酸可导致肾小管坏死。小林制药于8月宣布将停止其红曲米业务。

*肾小管坏死：一种肾脏中帮助过滤废物的小管受损的病症。*
</TabItem>
<TabItem value="score">
	| Scores     | Value   | Explanation |
	| -------- | ------- | ------- |
	| Objectivity  | 5    | Balanced reporting with factual support.    |
	| Social Impact | 5     | Significant influence on public opinion.    |
	| Credibility    | 5    | Solid evidence from authoritative sources.    |
	| Potential    | 6    | High potential for significant changes.    |
	| Practicality    | 4    | Highly practical, applicable to real problems.    |
	| Entertainment Value    | 2    | Slightly monotonous, few entertaining elements.    |
</TabItem>
</Tabs>

[Full article>>](https://asia.nikkei.com/Business/Pharmaceuticals/Class-action-filed-against-Kobayashi-Pharma-in-Taiwan-reports)
